B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver shield: nutrient may prevent chemo side effect in young leukemia patients
Disease control OngoingThis study tests whether adding levocarnitine, a natural nutrient, to standard chemotherapy can prevent severe liver damage in teens and young adults (ages 15-39) with leukemia or lymphoma. Liver toxicity from the chemotherapy drug asparaginase often forces treatment delays, whic…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 07:35 UTC
-
New chemo cocktail aims to beat tough childhood leukemia
Disease control OngoingThis large phase 3 trial studies whether different combinations and doses of chemotherapy drugs can better control high-risk B-acute lymphoblastic leukemia (B-ALL) in nearly 6,000 children and young adults. It includes a special group with Ph-like mutations who receive the target…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, BCR-ABL1-LIKE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 07:34 UTC